(19)
(11) EP 1 226 152 A2

(12)

(88) Date of publication A3:
10.05.2002

(43) Date of publication:
31.07.2002 Bulletin 2002/31

(21) Application number: 00975448.2

(22) Date of filing: 26.10.2000
(51) International Patent Classification (IPC)7C07H 21/04, C07K 2/00, C07K 4/00, C12N 1/20, C12N 15/09, C12N 15/63, C12N 15/74, C12P 21/00, C12P 21/04, C12P 21/06
(86) International application number:
PCT/US0029/690
(87) International publication number:
WO 0130/972 (03.05.2001 Gazette 2001/18)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 26.10.1999 US 161379 P

(71) Applicant: Digital Gene Technologies Inc.
La Jolla, CA 90237 (US)

(72) Inventors:
  • THOMAS, Elizabeth, A.
    Cardiff, CA 92007 (US)
  • SUTCLIFFE, J., Gregor
    Cardiff-by-the-sea, CA 92007 (US)
  • PRIBYL, Thomas, M.
    San Diego, CA 92109 (US)
  • HILBUSH, Brian
    San Diego, CA 92130 (US)
  • HASEL, Karl, W.
    Soloana Beach, CA 92075 (US)

(74) Representative: Kaiser, Jürgen, Dr.rer.nat.Dipl.-Chem. et al
Winter, Brandl, Fürniss, Hübner,Röss, Kaiser, PoltePartnerschaftPatent- und RechtsanwaltskanzleiAlois-Steinecker-Strasse 22
85354 Freising
85354 Freising (DE)

   


(54) REGULATION OF GENE EXPRESSION BY NEUROLEPTIC AGENTS